Literature DB >> 20938043

The genetics of Parkinson disease.

Lynn M Bekris1, Ignacio F Mata, Cyrus P Zabetian.   

Abstract

Parkinson disease (PD) is the second most common neurodegenerative disorder. In most instances, PD is thought to result from a complex interaction between multiple genetic and environmental factors, though rare monogenic forms of the disease do exist. Mutations in 6 genes (SNCA, LRRK2, PRKN, DJ1, PINK1, and ATP13A2) have conclusively been shown to cause familial parkinsonism. In addition, common variation in 3 genes (MAPT, LRRK2, and SNCA) and loss-of-function mutations in GBA have been well-validated as susceptibility factors for PD. The function of these genes and their contribution to PD pathogenesis remain to be fully elucidated. The prevalence, incidence, clinical manifestations, and genetic components of PD are discussed in this review.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20938043      PMCID: PMC3044594          DOI: 10.1177/0891988710383572

Source DB:  PubMed          Journal:  J Geriatr Psychiatry Neurol        ISSN: 0891-9887            Impact factor:   2.680


  210 in total

1.  Association between early-onset Parkinson's disease and mutations in the parkin gene.

Authors:  C B Lücking; A Dürr; V Bonifati; J Vaughan; G De Michele; T Gasser; B S Harhangi; G Meco; P Denèfle; N W Wood; Y Agid; A Brice
Journal:  N Engl J Med       Date:  2000-05-25       Impact factor: 91.245

Review 2.  Tau protein function in axonal formation.

Authors:  G Paglini; L Peris; F Mascotti; S Quiroga; A Caceres
Journal:  Neurochem Res       Date:  2000-01       Impact factor: 3.996

3.  Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid.

Authors:  K A Conway; J D Harper; P T Lansbury
Journal:  Biochemistry       Date:  2000-03-14       Impact factor: 3.162

4.  Molecular cloning of a mammalian nuclear phosphoprotein NUCKS, which serves as a substrate for Cdk1 in vivo.

Authors:  A C Ostvold; J H Norum; S Mathiesen; B Wanvik; I Sefland; K Grundt
Journal:  Eur J Biochem       Date:  2001-04

5.  Parkin deletions in a family with adult-onset, tremor-dominant parkinsonism: expanding the phenotype.

Authors:  C Klein; P P Pramstaller; B Kis; C C Page; M Kann; J Leung; H Woodward; C C Castellan; M Scherer; P Vieregge; X O Breakefield; P L Kramer; L J Ozelius
Journal:  Ann Neurol       Date:  2000-07       Impact factor: 10.422

6.  Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders.

Authors:  E Masliah; E Rockenstein; I Veinbergs; M Mallory; M Hashimoto; A Takeda; Y Sagara; A Sisk; L Mucke
Journal:  Science       Date:  2000-02-18       Impact factor: 47.728

7.  Prevalence of Parkinson's disease in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group.

Authors:  M C de Rijk; L J Launer; K Berger; M M Breteler; J F Dartigues; M Baldereschi; L Fratiglioni; A Lobo; J Martinez-Lage; C Trenkwalder; A Hofman
Journal:  Neurology       Date:  2000       Impact factor: 9.910

8.  alpha-Synuclein membrane interactions and lipid specificity.

Authors:  E Jo; J McLaurin; C M Yip; P St George-Hyslop; P E Fraser
Journal:  J Biol Chem       Date:  2000-11-03       Impact factor: 5.157

9.  Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase.

Authors:  H Shimura; N Hattori; S i Kubo; Y Mizuno; S Asakawa; S Minoshima; N Shimizu; K Iwai; T Chiba; K Tanaka; T Suzuki
Journal:  Nat Genet       Date:  2000-07       Impact factor: 38.330

10.  Localization of a novel locus for autosomal recessive early-onset parkinsonism, PARK6, on human chromosome 1p35-p36.

Authors:  E M Valente; A R Bentivoglio; P H Dixon; A Ferraris; T Ialongo; M Frontali; A Albanese; N W Wood
Journal:  Am J Hum Genet       Date:  2001-03-07       Impact factor: 11.025

View more
  102 in total

Review 1.  α6β2* and α4β2* nicotinic acetylcholine receptors as drug targets for Parkinson's disease.

Authors:  Maryka Quik; Susan Wonnacott
Journal:  Pharmacol Rev       Date:  2011-12       Impact factor: 25.468

Review 2.  Rodent models and contemporary molecular techniques: notable feats yet incomplete explanations of Parkinson's disease pathogenesis.

Authors:  Sharawan Yadav; Anubhuti Dixit; Sonal Agrawal; Ashish Singh; Garima Srivastava; Anand Kumar Singh; Pramod Kumar Srivastava; Om Prakash; Mahendra Pratap Singh
Journal:  Mol Neurobiol       Date:  2012-06-27       Impact factor: 5.590

Review 3.  Gene-environment interactions in Parkinson's disease: specific evidence in humans and mammalian models.

Authors:  Jason R Cannon; J Timothy Greenamyre
Journal:  Neurobiol Dis       Date:  2012-07-07       Impact factor: 5.996

4.  Genetic association of cyclooxygenase-2 gene polymorphisms with Parkinson's disease susceptibility in Chinese Han population.

Authors:  Yi Dai; Yuquan Wu; Yansheng Li
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

5.  Accurate prediction of a minimal region around a genetic association signal that contains the causal variant.

Authors:  Zoltán Bochdanovits; Javier Simón-Sánchez; Marianne Jonker; Witte J Hoogendijk; Aad van der Vaart; Peter Heutink
Journal:  Eur J Hum Genet       Date:  2013-06-05       Impact factor: 4.246

6.  Spatial distribution of 5-hydroxymethyl cytosine in rat brain and temporal distribution in striatum.

Authors:  Tingting Zheng; Qing Lv; Xiaoguang Lei; Xinzhen Yin; Baorong Zhang
Journal:  Neurochem Res       Date:  2015-02-03       Impact factor: 3.996

7.  The MAPT H1 haplotype is associated with tangle-predominant dementia.

Authors:  Ismael Santa-Maria; Aya Haggiagi; Xinmin Liu; Jessica Wasserscheid; Peter T Nelson; Ken Dewar; Lorraine N Clark; John F Crary
Journal:  Acta Neuropathol       Date:  2012-07-17       Impact factor: 17.088

8.  Regulation of parkin and PINK1 by neddylation.

Authors:  Yeun Su Choo; Georg Vogler; Danling Wang; Sreehari Kalvakuri; Anton Iliuk; W Andy Tao; Rolf Bodmer; Zhuohua Zhang
Journal:  Hum Mol Genet       Date:  2012-03-02       Impact factor: 6.150

9.  Protective Effects of Fisetin Against 6-OHDA-Induced Apoptosis by Activation of PI3K-Akt Signaling in Human Neuroblastoma SH-SY5Y Cells.

Authors:  Ryoko Watanabe; Takumi Kurose; Yuta Morishige; Ko Fujimori
Journal:  Neurochem Res       Date:  2017-12-04       Impact factor: 3.996

10.  Expression of human E46K-mutated α-synuclein in BAC-transgenic rats replicates early-stage Parkinson's disease features and enhances vulnerability to mitochondrial impairment.

Authors:  Jason R Cannon; Kindiya D Geghman; Victor Tapias; Thomas Sew; Michelle K Dail; Chenjian Li; J Timothy Greenamyre
Journal:  Exp Neurol       Date:  2012-11-12       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.